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Previous studies using cell culture systems to evaluate LAT expression demonstrated that the LAT promoter expresses
at much higher levels in neuroblastoma cell lines than fibroblast lines. The high level of LAT expression in neuronal-derived
cell lines correlates with the high level of LAT accumulation observed in sensory ganglia neurons during a latent infection.
We have found that using LAT promoters to express reporter genes from recombinant viruses in vivo produces high levels
of LAT promoter activity in the epithelium of the mouse foot. An analysis of LAT promoter activity during an acute infection
in the mouse clearly demonstrates that in contrast to studies performed with selected cell lines, the LAT promoter expresses
similar levels of reporter gene product in peripheral cells and in neurons. In addition, the amount of reporter gene product
is higher when the LAT promoter is located within the RL as compared to the UL region, and when expression is adjusted for
copy number of the reporter construct, expression is roughly the same. These results suggest the activity of the LAT
promoter varies greatly according to cell type and that high levels of expression is not limited solely to neurons, especially
in the in vivo setting. © 1999 Academic Press
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Herpes simplex virus type-1 (HSV-1) is an alphaherpes-
irus capable of establishing a life-long latent infection (for
review see Wagner and Bloom, 1997). Infection by HSV-1
sually begins at the skin or mucosal epithelium and sub-
equently spreads to the sensory ganglia, whose nerve
rocesses contact the primary site of infection. Once within
hese neurons of the sensory ganglia the virus may con-
inue the productive infection in certain cells expressing all
hree viral gene classes (immediate early, IE; early, E; late,
;) or the virus may enter a state of latency characterized by
he absence of lytic gene transcription. During latency there
emains one active transcription unit known as the latency-
ssociated transcription unit. The products of this transcrip-
ion unit are several species of RNA known as the latency-
ssociated transcripts (LATs).
Although several of the LAT RNAs are stable and
ccumulate in latent neurons, their specific mode of
ction remains unclear. Evidence suggests that LATs
lay some role in facilitating reactivation of HSV from
atency (Bloom et al., 1994; Block et al., 1993; Hill et al.,
990; Krause et al., 1995; Leib et al., 1989; Perng et al.,
994). LATs have also been suggested to impact the
stablishment of latency in the mouse model (Garber et
l., 1997; Kramer et al., 1998; Sawtell and Thompson,
992; Thompson and Sawtell, 1997).
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384It has been demonstrated that in acutely infected mouse
ensory ganglia the majority of infected neurons can be
een to either express LAT or HSV antigen (indicating a
roductive infection), but not both (Margolis et al., 1992).
his observation is consistent with models suggesting that
AT could function in downregulating acute transcription
Garber et al., 1997). In order to investigate any impact of
AT on the acute infection as it occurs in the animal, it is
mportant to first define the cell specificity of LAT expres-
ion in vivo, within the specific tissues in which the virus
ormally replicates during a natural infection.
Many of our current models describing the control of
AT expression are derived from the transfection of plas-
ids containing modified LAT promoter constructs con-
rolling the expression of a reporter gene in cultured
ells. HSV LAT promoter activity is at least 5-fold greater
n neuroblastoma cells than in cells of nonneuronal ori-
in (Batchelor and O’Hare, 1990; Zwaagstra et al., 1990).
pecific regions of the LAT promoter were shown to be
esponsible for this specificity in cell culture (Batchelor
nd O’Hare, 1992; Devi-Rao et al., 1991). The sequences
esponsible for the greatest amount of the neuronal-
pecific activity reside between 2251 and 2143 (relative
o the LAT transcriptional start site), and deletion of these
equences reduces LAT expression 35-fold in neuro-
lastoma cell lines, while having little effect on the low
ranscriptional activity in cells of nonneuronal origin.
More recently modified LAT promoters controlling re-
orter genes have been introduced into recombinant
irus for study of tissue-specific expression. Dobson et
l. (1995) found that a similar region of the LAT promoter
as important for activity in dorsal root ganglia during
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385ACUTE HSV-1 LAT PROMOTER EXPRESSION IN VIVOcute infection in mice. Further, Huang et al. (1994) in-
erted the promoter controlling the expression of LAT
rom a related alphaherpesvirus, pseudorabies virus
PRV) (Priola et al., 1990; Priola and Stevens, 1991), into
ither its cognate location in the RL or into a heterolo-
ous location in the UL. This recombinant HSV demon-
trated both a strong specificity for expression during
roductive infection of cultured cells and a distinct pref-
rence for a location in the RL.
Since the acute infection of HSV in vivo involves a variety
f different cell types, both in the periphery (site of primary
nfection) and in the sensory ganglia, we used a number of
ell-characterized recombinant HSV-1 viruses containing
AT promoter–reporter constructs along with equivalent
onstructs containing an acute phase HSV promoter. These
iruses were used to examine the differential specificity of
AT expression in murine peripheral and ganglionic tissue
uring the acute phase of infection.
Specifically our aims in this study were (1) to deter-
ine the activity of the LAT promoter in peripheral vs
euronal tissue and (2) to determine whether the
enomic location of LAT promoter effected its tissue-
pecific expression. The results revealed that LAT ex-
ression in the periphery (skin) was significantly higher
han expected from studies of transfected and infected
ell culture systems. In fact, LAT promoter activity in the
eet of infected animals 4 days postinfection was com-
arable to that of the dorsal root ganglia (DRG) of the
ame animals.
This rather unexpected result was obtained using PRV
AT promoter constructs in the 17syn1 strain of HSV-1
nd using the HSV LAT promoter controlling expression
f the same reporter in recombinant viruses derived from
he KOS strain of HSV-1. Thus, the PRV LAT promoter has
xpression characteristics similar to those of the HSV
AT promoter in mice feet and DRGs, and there is no
ifference in expression characteristics between a KOS
nd 17syn1 background. Furthermore, when adjusted for
he copy number of LAT promoter–reporter constructs,
enomic location also did not have an effect on the
attern of LAT promoter activity. Finally, we confirmed the
riginal observations that the PRV LAT promoter–re-
orter did exhibit a distinct preference for expression in
ultured neuroblastoma cells and when the promoter is
resent in the RL region of the HSV genome. Such results
emonstrate that care must be used in applying the
esults of studies of tissue specificity in cell culture to
tudies on the whole animal.
RESULTS
cute replication characteristics of the LAT reporter
iruses
Huang et al. (1994) showed that the activity of the PRV
AT promoter when recombined into HSV is markedly
igher in productively infected murine neuro 2A cells than it is in cultured fibroblasts. Further, its activity is
ependent on its genomic location, since moving the
romoter to the UL region reduced the levels of transcrip-
ion. The initial aim of the present study was to determine
hether the genomic context of the PRV LAT promoter
nfluenced the magnitude of its expression in vivo in the
ontext of the tissues in which the virus replicates during
n acute infection. The viruses used in this study are
iagrammed in Fig. 1 (see Materials and Methods for
itations).
We measured promoter activity as a function of re-
orter (b-galactosidase) activity and compared LAT pro-
oter-controlled expression with expression controlled
y the dUTPase promoter in the same location. The
UTPase promoter is characteristic of a typical early
SV-1 promoter and has been well characterized (Goo-
art et al., 1992; Pande et al., 1998). Together these
iruses allowed us to ensure that any measured posi-
ional effects were promoter specific and not a general
ffect of site of insertion. In addition, the dUTPase pro-
oter constructs also allow direct comparison of levels
f LAT promoter activity with the activity of a typical
roductive phase promoter.
In order to determine the relative capability of these
our mutants to infect and spread to the tissues of inter-
st in the mouse, we first performed a tracer study. This
as essential in order to determine whether the in vivo
eporter expression from these viruses could be reliably
ompared with each other. Our primary concern focused
n the constructs with insertions into the gC locus since
eletion of this glycoprotein has been reported to have a
ole in patterns of viral pathogenesis and spread in some
nimal systems (Friedman et al., 1996). While the mag-
itude of the impact of this locus on murine pathogene-
is has been debatable, we considered it of paramount
mportance to directly evaluate the effect of the specific
nsertions within the background of 17syn1 using the
ootpad route of infection.
Groups of four mice were infected at a m.o.i. of 2 3 106
FU/mouse with the two PRV LAT promoter–reporter
ecombinants and the two dUTPase promoter–reporter
ecombinants. Four days postinfection these mice were
acrificed and the amounts of infectious virus present in
he feet and spinal ganglia determined. Viral yields from
he homogenates of acutely infected feet were compa-
able for all four recombinants, ranging from 5 3 105 to
3 106 PFU/gram of tissue (Fig. 2B). In contrast, viral
ields recovered from the DRG (Fig. 2A) ranged from 1 3
06 PFU/gram of tissue in the case of PRV/gC to 5 3 107
FU/gram of tissue in the case of the dUTPase/LAT (Fig.
A). Overall, inactivation of gC by insertion of the reporter
t this locus resulted in a 5- to 10-fold reduction in
ecovery of virus from the spinal ganglia.
These results indicated that while the insertion of the
-galactosidase reporter at the gC locus did not substan-
ially reduce viral replication at the initial site of infection
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386 JARMAN, WAGNER, AND BLOOMfeet), spread to the DRG was affected. The fact that the
mpairment was essentially equivalent (ca. 1 log compared
o RL insertions) whether the insertion was with the LAT
romoter–reporter or dUTPase promoter–reporter, how-
ver, meant that we could normalize any differences in
xpression of b-galactosidase at these two sites. This is
ossible because the two dUTPase promoter–reporter vi-
uses (where the dUTPase promoter is inserted at either
he gC or RL locations) could be used to control for differ-
nces in levels of viral gene expression resulting from
educed invasion of the DRG by gC recombinants.
istribution of X-Gal staining in feet and dorsal root
anglia during acute infection
We next performed X-Gal staining on tissue whole
FIG. 1. Sites of insertion of the various promoters controlling expre
nsertion of the promoter–reporter construct into and replacing the LAT
romoter inserted into the 17syn1 parent strain. Recombinant KOS/6
ownstream in HSV strain KOS. (B) Substitutional insertion of the prom
nd HSV dUTPase early promoter–reporter inserted into the 17syn1 pare
nserted in parental HSV strain KOS. These constructs have been des
argolis et al., 1992; Huang et al., 1994.ounts in order to determine the gross pattern of b-ga- aactosidase expression in the foot and DRG following
ootpad inoculation. Groups of four mice were infected
ilaterally on both rear footpads with PRV/LAT, PRV/gC,
UTPase/LAT, dUTPase/gC, KOS/1, KOS/62, or 17syn1
irus and sacrificed 4 days postinfection. The DRG and
eet were removed and assayed for the reporter gene
roduct b-galactosidase by staining with X-Gal.
Infection with viruses containing the PRV LAT reporter
onstructs exhibited readily apparent staining in the
RGs when compared to the dUTPase viruses, though
he intensity of staining was marginally less, which sug-
ests less promoter activity (Fig. 3). Genomic location did
ot appear to have a major impact on the expression of
he PRV promoter–reporter in DRG. At gross levels the
ntensity of the staining was only slightly reduced, if at
of reporter b-galactosidase into the HSV genome. (A) Substitutional
oter and 59 region of LAT. PRV LAT promoter and HSV dUTPase early
ains the HSV LAT promoter and the reporter gene is inserted just
porter construct into and inactivating gC in the UL. PRV LAT promoter
rain. KOS/1 utilizes the HSV LAT promoter controlling the reporter gene
and characterized in the following publications: Goodart et al., 1992;ssion
prom
2-3 ret
oter–re
ntal st
cribedll, when one copy of the reporter cassette was located
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387ACUTE HSV-1 LAT PROMOTER EXPRESSION IN VIVOn the UL compared to two copies in the RL. The dUTPase
romoter–reporter constructs demonstrated a similar re-
ult; however, a somewhat higher activity of the dUTPase
romoter in both genomic locations was apparent. Fi-
ally, the 17syn1 control infections produced no staining,
s expected.
We employed the same technique to examine LAT
xpression in the feet of acutely infected mice and ob-
erved some unanticipated results (Fig. 4). While the
ost intense staining was seen in the feet infected with
he dUTPase/LAT and dUTPase/gC viruses, the PRV/LAT
nd PRV/gC viruses also demonstrated quite significant
evels of X-Gal staining. For all of these viruses, the
reatest amount of staining was seen in the epithelium
ircumscribing the abraded area on the ventral surface
f the footpad. This region of staining radiated out 1–2
m from the abraded region (site of the inoculation).
There was also observable staining observed on the
orsal surface of the foot. This dorsal staining was pri-
arily localized at the anterior third of the foot and
erminated just at the base of the metatarsals. It should
e noted that the procedure used to infect the mice (see
aterials and Methods) minimizes the likelihood of virus
ontacting the dorsal aspect of the foot during the inoc-
lation of the footpad. We suggest that the pattern ob-
erved with defined borders is the result of anterograde
ransport of the virus back to the foot following replica-
ion in the DRG.
The genomic location of the dUTPase promoter–re-
orter cassette into the virus appeared to have no de-
ectable effect on the amount of X-Gal staining in the feet.
FIG. 2. Recovery of infectious virus from the dorsal root ganglia (A) and
n rabbit skin monolayers and are reported as plaque-forming units pe
rocessed. (A) Less virus was recovered when the reporter gene was in
irus. (B) Virus recovered from virally infected feet.n contrast, the position of the PRV LAT promoter–re- porter insert did seem to impact the amount of X-Gal
taining: the PRV/gC construct clearly exhibited less
taining than the PRV/LAT recombinant (Fig. 4). Because
he levels of expression from the PRV LAT promoter were
igher than we expected in the feet, we considered the
ossibility that the levels of expression reflected a lack of
fficient downregulation of the PRV LAT by HSV ICP4.
his may result in poor binding of the HSV regulatory
rotein to the PRV IE protein-binding site present in an
nalogous position in the PRV LAT promoter. In order to
ddress this, we next examined staining patterns result-
ng from infection with the viruses KOS/1 and KOS/62,
hich contain the HSV-1 LAT promoter either at gC or at
AT, respectively (Fig. 1). These viruses are analogues to
RV/LAT and PRV/gC, except that they are in the back-
round of HSV-1 strain KOS instead of 17syn1 (Margolis
t al., 1992). We found that infections of mice with the
OS/1 and KOS/62 reporter viruses resulted in X-Gal
taining qualitatively identical to the patterns seen fol-
owing infection PRV/LAT and PRV/gC viruses (Figs. 3
nd 4).
One consideration in comparing the amount of X-Gal
taining between the feet and the ganglia is that even
hough day 4 is the peak of viral transcriptional activity
uring an acute infection in the ganglia, the first peak
ranscriptional activity in the feet has already passed.
herefore, in order to examine the kinetics of b-gal re-
orter activity in the feet as a function of time, a time
ourse was performed. Mice were infected with either
RV/gC or dUTPase/gC or 17syn1 as a control, and the
eet X-Gal stained at daily intervals between 1 and 4 days
) from infected mice. Homogenates of the two tissue types were plated
of tissue assayed. These graphs represent the average of four mice
nto glycoprotein C, resulting in about a 10-fold reduction in recoverablefeet (B
r gram
serted i.i. As can be seen in Fig. 5, in the case of the PRV/gC
e
v
r
388 JARMAN, WAGNER, AND BLOOMFIG. 3. X-Gal staining of acutely infected dorsal root ganglia. The virus used for infection of the mice is indicated in the lefthand column and the
xperimental mouse number is show across the top. The dorsal root ganglia (L4–L6) were harvested from mice acutely infected with the indicated
irus. The ganglia were stained in b-galactosidase staining solution containing X-Gal for 12 h at 31°C (see Materials and Methods). Intensity of blue
eflects the relative amount of X-Gal staining in each ganglion.
X
t
389ACUTE HSV-1 LAT PROMOTER EXPRESSION IN VIVOFIG. 4. X-Gal staining of HSV-infected feet. The feet from each acutely infected mouse were stained in b-galactosidase staining solution containing
-Gal for 12 h at 31°C. The lefthand column identifies the virus that the mice were infected with and the experimental animal number is listed at theop of the composite. The dorsal surface of the foot is positioned on the top and the ventral portion (footpad) is positioned below.
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390 JARMAN, WAGNER, AND BLOOMirus, X-Gal staining can first be detected 2 days postin-
ection and increases in intensity through day 4. In the
ase of the dUTPase/gC virus, the X-Gal staining first
ecomes visible at day 1 and increases in intensity
hrough day 4. These results indicate that the peak in
ccumulation of b-gal in the feet does not occur prior to
ay 4 and that day 4 is an appropriate time to compare
nd measure the accumulation of this reporter in the
eet.
uantitation of b-galactosidase activity present
n feet and DRGs by CPRG assay
The X-Gal staining procedure allowed us to determine
hat there was significant expression from the LAT re-
orter viruses in the feet of virally infected mice at 4 days
ostinfection. In order to quantitate these observations
e next assayed levels of b-galactosidase activity using
standard colorimetric assay with the chlorophenol-red-
-D-galactopyranoside (CRPG) substrate (Lokensgard et
l., 1994). Four days postinfection the mice were sacri-
iced, dorsal root ganglia and feet were removed and
omogenized, and dilutions of the homogenates as-
ayed for b-gal activity and expressed as units per gram
f tissue.
b-Galactosidase activity from mice infected with re-
ombinant viruses containing the dUTPase promoter–
eporter insert was the highest in DRG (Fig. 6B). This
evel was approximately two- to threefold higher than the
FIG. 5. Time course of b-galactosidase expression in the feet during
UTPase recombinants as assessed by X-Gal staining of feet. The LAT
ay 2 to be detected by X-Gal staining and progresses through day 4 at
evels of b-galactosidase by day 1 as indicated by the X-Gal stainingmount of enzyme recovered following infection with any Lf the viruses with a LAT promoter–reporter construct
nserted. This result is consistent with the in situ X-Gal
taining assay.
Quantitative analysis of LAT expression in the feet also
as consistent with the observations seen in the X-Gal
taining experiment, with the exception that the high
evel of staining seen with the dUTPase/gC virus was not
ccurately reflected. While infection with dUTPase vi-
uses resulted in recovery of the highest reporter enzyme
ctivity, both the PRV and HSV LAT promoters exhibit
eadily measurable levels of activity (Fig. 6A). With the
ajority of the constructs, the induced b-galactosidase
ctivity was approximately twofold less when expression
as controlled by the LAT promoter than by the analo-
ous dUTPase promoter–reporter construct in the feet
hen homologous viruses were compared (though the
RV/LAT was 15 the level of the dUTPase LAT).
In both tissues there was a general correlation be-
ween the position of insertion and activity, this was
vidently directly related to copy number of the reporter
ince promoters at the gC site were consistently 12 to
1
3 as
ctive as the constructs with the insertions at LAT.
ssessment of the relative activity of the LAT
nd dUTPase promoters in feet and DRGs
ollowing acute infection
The CPRG assays of the feet and dorsal root ganglia
rovided evidence that there is significant activity of the
infection. A progression of infection is shown for both the PRV/gC and
ter construct PRV/gC appears to produce enough b-galactosidase by
k of the infection. The acute promoter construct dUTPase/gC produces
gresses to high levels by day 4.acute
promo
the peaAT promoters in peripheral (feet) tissue during an acute
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391ACUTE HSV-1 LAT PROMOTER EXPRESSION IN VIVOnfection. We estimated and compared the relative activ-
ty of b-galactosidase in tissues infected with LAT pro-
oter–reporter containing viruses to the dUTPase pro-
oter–reporter containing virus in the same tissue.
hese ratios are expressed as percentages in Fig. 7. As
een from these data, the PRV/LAT and HSV/LAT con-
tructs show 33 and 27% of the activity of the comparable
UTPase construct in the DRG. This is compared to the
FIG. 6. b-Galactosidase activity in the feet and DRG of acutely infec
see Materials and Methods). (B) Dorsal root ganglia. These graphs re
FIG. 7. Relative LAT promoter activity in the feet and ganglia. LAT
romoter activity is expressed as the percentage of dUTPase promoter
ctivity for each LAT promoter (PrV or HSV) at each genomic location
RL or gC) in each tissue (ganglia or feet). This comparison takes into
onsideration differences in the number of “infectable” cells between
he dorsal root ganglia and the feet and allows the relative promoter
ctivities to be compared as ratios of b-gal activity between these twoonatomic locations.8 and 45% observed for the same promoters located at
C. In the feet, the PRV/LAT and HSV/LAT constructs
how 19 and 40% of the activity of the comparable
UTPase construct.
One difficulty in estimating promoter strength in vivo
y this approach is adjusting for comparable numbers of
nfected cells. The analysis in Fig. 7 allowed us to nor-
alize relative expression between the ganglia and feet
using the dUTPase promoter as our reference). This
ompensates for the fact that the units/weight compari-
on in Fig. 6 do not accurately compare feet and ganglia
ecause the foot is composed of a large percentage of
one and connective tissue. In addition, the X-Gal assays
lso reflect that only a portion of the total foot epithelium
s infected.
The comparison summarized in Fig. 7 shows that the
evels of LAT expression in the feet is comparable to that
een in the DRGs during an acute infection. This clearly
hows that when the tissues samples are adjusted for
he number of infected cells (indicated by the early pro-
oter expression) expressions from the LAT promoters
re very similar regardless of the tissue being assayed.
nalysis of acute expression kinetics of the reporter
onstructs
To determine the kinetics of expression of the b-ga-
actosidase produced by the reporter viruses during an
cute infection, we performed a time course. Mice in-
ected with PRV/gC or dUTPase/gC were assayed by
-Gal staining (Fig. 5), PCR, and RT–PCR analysis (Figs.
A and 8B, respectively, and Table 1). X-Gal staining
evealed a progression of infection over the 4-day infec-
ion, ending with a staining pattern similar to what was
e. (A) b-Gal activity in the feet as CPRG assay of the infected tissues
t the average of four tissue samples (from four mice) for each virus.ted micbserved in Fig. 4. The PRV/gC infection reveals very
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392 JARMAN, WAGNER, AND BLOOMittle staining during the first 2 days of infection, which
ay be due to limits of sensitivity of the X-Gal staining
rocedure for small amounts of b-gal. However, at the
eak of infection there appears to be significant produc-
ion of b-gal by each of the viruses. b-Gal production
rom the acute promoter resulted in positive X-Gal stain-
ng on the first day of infection and progressed through
eak infection at day 4, again resulting in a pattern
imilar to that observed in Fig. 4.
In order to determine whether the detection of b-ga-
actosidase activity as a result of reporter gene expres-
ion correlated with transcription from these promoters,
FIG. 8. PCR and RT–PCR detection of viral genomes and b-galacto-
idase transcripts in mice feet. (A) Quantitative PCR detecting viral
enomes in acutely infected mice feet over a period of 4 days following
nfection. Sensitivity of PCR reactions (shown right) was determined by
itrating dilutions of plasmid target DNA into DNA extracted from un-
nfected mice. (B) RT–PCR analysis of b-galactosidase transcripts. The
AT promoter construct PRV/gC shows peak production at day 4, while
he peak of b-galactosidase transcription of the acute promoter con-
truct dUTPase/gC appears to be at day 2. b-Galactosidase primer
ensitivity (shown right) is 100 copies.
T
Relative HSV (b-Galactosidase)/APRTa Ratios in Mice
Feet
DNA RNA
PRV/gC DUTPase/GC PRV/gC DUTPa
ay 1 2.3 0.3 0.45 0.2
ay 2 1.7 3.8 1.13 1.5
ay 3 1.57 1.09 0.53 0.8
ay 4 2.2 1.10 0.96 0.7
a HSV and APRT DNA data obtained by PCR as described under Mat
CR products obtained by exposing the gels to phosphoimager screens ande performed RT–PCR using primers specific for b-gal to
etect b-gal RNA in feet and DRGs infected with the
eporter viruses. We observed two peaks of RNA produc-
ion (at days 1 and 4) for the LAT promoter construct and
n early peak of b-gal RNA production at day 2 for the
cute promoter construct. Although the total amounts of
NA detected were low, both the LAT promoter and
UTPase promoters produced comparable amounts (see
ig. 8B and Table 1). The kinetics of RNA production is in
greement with the temporal regulation of the infection
nd in the relative amounts of b-galactosidase activity
hat we observed in the enzymatic assays.
To determine the amounts of viral genomes that were
resent in these infections we performed semiquantita-
ive PCR using HSV polymerase primers as shown in Fig.
A. Again there appear to be two peaks of infection, at
ays 1 and 4, for the LAT promoter constructs and a peak
f infection at day 2 for the dUTPase/gC virus in the feet.
hese peaks correspond with the peaks of RNA produc-
ion in the feet (see Table 1).
nalysis of b-galactosidase expression from the
ecombinant viruses in vitro
Since the in vivo data demonstrated higher levels of
AT expression in the feet than was expected based on
revious in vitro studies, we wished to evaluate these
articular viruses in vitro. The six recombinant viruses
sed in this study, along with 17syn1 as a control, were
sed to infect confluent monolayers of neuro 2A, Vero,
nd rabbit skin cells. The b-galactosidase activity was
etermined by the CPRG assay. The data shown in Fig. 9
emonstrate that the LAT promoter–reporter inserts in
he RL are expressed at 2- to 8-fold higher levels in
euro-2A cells than in either Vero or rabbit skin cells in
itro; this result is in full agreement with earlier reports
Huang et al., 1994). It is also striking that the level of
xpression of the dUTPase promoter–reporter constructs
s between 10- and 100-fold higher than is the LAT
romoter in vitro, whereas in the mouse the difference is
n the order of 2-fold.
d DRG Acutely Infected with PRV/gC or dUTPase/gC
DRG
DNA RNA
PRV/gC DUTPase/gC PRV/gC DUTPase/gC
1.86 2.31 0.33 0.22
0.73 3.83 0.89 0.44
1.82 1.27 0.50 0.5.
1.26 2.61 0.56 0.56
nd Methods. The values presented are relative intensity values for theABLE 1
Feet an
se/gC
7
7
4
5
erials a
quantified using ImageQuant V5.0.
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393ACUTE HSV-1 LAT PROMOTER EXPRESSION IN VIVOapping of the transcriptional start site
f the b-galactosidase mRNA
In order to ensure that the RNA (and resulting b-gal
roduct) that was being detected in the feet was being
ranscribed from the LAT promoter as opposed to being
ead-through transcription from an upstream promoter,
e mapped RNA isolated from the feet of mice infected
ith the PRV/gC construct 4 days postinfection. cDNA
roduced from this RNA was subjected to PCR with three
ombinations of primers (Fig. 10A), with the anti-sense
rimer anchored in the LacZ coding region (P1) and the
ense primer specific for the 59 UTR of the reporter
assette (P2) or within the LAT promoter (P3 and P4). As
hown in Fig. 10B (lanes 5–7), only the P1/P2 combina-
ion generated detectable product, indicating that the
-gal RNA being produced in the feet by this reporter
irus is transcribed primarily from the LAT promoter.
igure 10B (lanes 2–4) shows PCR reactions performed
sing these primers on DNA isolated from the same
nfected feet as a control for these PCR reactions.
DISCUSSION
Previous studies on LAT promoter expression in vitro
FIG. 9. LAT promoter activity in vitro. Neuro 2A, Vero, and rabbit sk
ostinfection the cell were harvested and assayed for b-galactosidase
ctivity in each of the cell lines using the dUTPase promoter reporter
onstructs. The LAT promoter reporter constructs in the RL exhibited tave been used to argue that its activity is neuron spe- Dific. Deletions of neuron expression elements drasti-
ally reduce LAT expression in neuroblastoma cell lines,
ut their effect on LAT expression in latently infected
eurons has yet to be determined. While these elements
ay well have a role in the biological manifestations of
atency, there is ample evidence that LAT promoter ex-
ression is not confined to neurons in either latently or
roductively infected tissue. Thus, we have quantitated
AT expression in the corneas of latently infected rab-
its, and LAT expression in cultured cells is of sufficiently
igh levels to have allowed analysis of the structure of
he transcript (Devi-Rao et al., 1997; Wagner and Bloom,
997). These experiments did not address the relative
ontribution of LAT promoter activity vs transcript stabil-
ty, but suggested that the deletion of neuronal elements
as very little effect on increasing or decreasing the
elatively low activity seen in cells of nonneuronal origin.
The present study examined LAT expression in vivo
uring an acute infection of the mouse and revealed
hree important conclusions: (1) The LAT promoter is
xpressed at significant levels in nonneuronal cells,
uch as the epithelium of the foot. (2) When normalized
or the ability of virus to infect the tissue in question, LAT
romoter activity is roughly the same in the feet and
s were infected at a m.o.i. of 5 with the recombinant viruses. At 8 h
ty using CPRG (see Materials and Methods). As shown, the levels of
was 10- to 100-fold greater than those of the LAT promoter reporter
test differences in neuronal specificity.in cell
activi
virusesRG. And (3) there was no substantial difference in LAT
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394 JARMAN, WAGNER, AND BLOOMromoter activity whether situated in the unique long
egment (at gC) or in its native location in the long
epeat. These results suggest that the functional role of
AT in mediating establishment and/or reactivation could
e assessed independently of genome position effects
n the transcription of LAT. This last conclusion is im-
ortant in that it allows the design of recombinant vi-
uses with an eye toward establishing whether LAT’s
ction in reactivation is via cis- or trans-acting mecha-
isms. Therefore, our findings here indicate that in vivo,
igh-level LAT promoter specificity is not markedly re-
tricted to neurons. This result is not to say that there are
ot be neuronal-specific elements present within the
romoter or that such elements may play an important
ole in the biology of LAT, but it does say that LAT activity
n other tissues must be fully considered. In light of our
resent observations, it is important to bear in mind that
AT is not expressed in all cells equally. Margolis and
o-workers noted that during an acute infection of mouse
pinal ganglia that there were different levels of expres-
ion within different neurons (Margolis et al., 1992). While
ot a quantitative assessment, this suggests that other
egulatory processes are involved. In support of this
oint, several groups have reported that during latent
nfections there are many neurons harboring viral ge-
omes that express very little (if any) LAT (Gressens and
FIG. 10. Mapping of the 59 b-galactosidase transcript. RT–PCR of
NA from mice feet infected with the PRVgC construct (4 days p.i.). (A)
iagram showing the location of the four PCR primers (P1–P4) used to
ap the location of the b-gal transcripts. P1 is the antisense anchor
rimer located entirely within the LacZ coding region. P2 is a sense
rimer positioned within the predicted UTR of the PRV LAT construct.
3 and P4 are sense primers located within the PRV LAT promoter. (B)
CR analysis of the cDNA isolated from the infected feet (lanes 5–7).
anes 2–4 are PCRs of total DNA isolated from the infected feet as a
ontrol for the PCR reactions with each primer concentration. The
redicted sizes of the PCR products are P1/P2, 385 bp; P1/P3, 450 bp;
nd P1/P4, 521 bp.artin, 1994; Mehta et al., 1995). Finally, in cell culture Kystems there has been evidence of different levels of
AT expression in different cell lines (Dobson et al., 1995;
uang et al., 1994; Lokensgard et al., 1994).
While the approach we have used in this paper to
xamine gene expression in vivo is one that has been
pplied by many research workers, it is important to
ecognize caveats in interpreting the data from such
tudies. A major difficulty arises in comparing levels of
xpression from one tissue type to another. Unlike in cell
ulture, it is difficult to standardize for how many cells
re infected in a given tissue. In addition different tissues
ave different properties, such as barriers to viral spread,
nd different levels of exposure to immune mediators.
ere we have employed a reference promoter (dUTPase)
o act as a standard for the level of acute infection. Use
f this reference obviously assumes similar levels of
cute transcription of this gene in different environments.
ven so, based on the benchmarks of gross X-Gal stain-
ng and viral yields from each of the tissues, we feel that
his analysis has been useful here in defining differences
n tropic patterns of expression. Ultimately, the expres-
ion data obtained from this in vivo assay will need to be
eplicated in a more defined in vitro system to reconcile
he in vivo differences from expression in the cell lines.
A key question posed by this study is what is the
xplanation for the lack of correlation between what is
een in cell culture and in the epithelium of the mouse
uring an acute infection. One possibility is that the cell
ines used to date do not represent the cells in which the
irus is replicating within the animal. Another possibility
s that the state of cell cycle or division plays a role in the
egulation of acute and/or LAT gene expression. A third
ossibility is that other external mediators not present in
onventional cell culture systems are playing a role. For
xample, during the acute infection there is an inflam-
atory or injury response that exposes the cells to me-
iators that could impact the cell’s transcriptional status
Lee et al., 1995; Rajan et al., 1995). These possibilities
re currently under investigation.
Whatever the explanation for the high levels of LAT
xpression in nonneuronal sites during an acute infec-
ion, high levels of LAT expression during the acute
nfection need to be considered in assessing models
nvolving LAT in modulation of the acute infection and
otentially in establishment of latency. It is likely that
tudy of these regulatory issues will need to be looked at
n a specific cell-type basis.
MATERIALS AND METHODS
ells and viruses
The viruses used in this study are shown in Fig. 1; all
ave been previously described. Two constructs in the
OS strain, KOS/1 (HSV LAT promoter driving a b-galac-
osidase reporter gene at the gC locus in the UL), and
OS/62-3 (HSV LAT promoter driving this reporter in-
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395ACUTE HSV-1 LAT PROMOTER EXPRESSION IN VIVOerted in the RL replacing the 59 portion of LAT) were
haracterized by Margolis et al. (1992). The 17syn1-
ased constructs PRV/LAT (PRV LAT promoter control-
ing b-galactosidase inserted in the RL replacing the 59
ortion of LAT; PRV/gC (PRV LAT promoter controlling
-galactosidase inserted in the gC locus); dUTPase/LAT
HSV-1 dUTPase promoter controlling b-galactosidase
nserted in the RL replacing the 59 portion of LAT); and
UTPase/gC (dUTPase LAT controlling b-galactosidase
nserted in the gC locus) were constructed and de-
cribed in Goodart et al. (1992) and Huang et al. (1994).
he reporter cassette present in the 17syn1-based vi-
uses contain the SV40 poly(A) termination sequence at
he 39 end of the LacZ gene.
Viruses were amplified and titrated on rabbit skin cells
s described previously, using Eagle’s minimal essential
edia (MEM; Gibco/BRL) supplemented with 5% calf
erum (Gibco/BRL) and antibiotic (250 U of penicillin, 250
g of streptomycin/ml, 2.5 mg/ml amphotericin B, and
92 mg L-glutamine/ml) (Bloom and Stevens, 1994).
euro-2A cells, a mouse neuroblastoma cell line, were
btained from ATCC and maintained in Eagle’s minimal
ssential media supplemented with 10% fetal bovine
erum (Atlanta Biological), antibiotics (penicillin, strepto-
ycin, amphotericin B, and glutamine), and nonessential
mino acids. Vero cells were maintained in Eagle’s min-
mal essential media supplemented with 10% FBS and
ntibiotics (penicillin, streptomycin, amphotericin B, and
lutamine).
ouse infections
Four- to six-week-old female Swiss-Webster mice
ere pretreated with 0.1 ml of a 10% saline solution
njected under each rear footpad. Four to six hours after
retreatment the mice were anesthetized and infected
ilaterally on the rear footpads with 2 3 106 PFU/mouse
or 17syn1 and the 17syn1-based recombinants (PRV and
UTPase viruses) and 4 3 106 PFU/mouse for the KOS-
ased viruses (KOS/1 and KOS/62). The keratinized epi-
helium was lightly abraded and the appropriate inocu-
um applied to the foot in a volume of 50 ml/footpad. The
noculum was spread over the surface with the side of
he pipet tip, and the virus allowed to adsorb for 30–45
in while the mice remained asleep on their backs. Four
ays postinfection the mice were sacrificed as described
elow and the spinal ganglia (L4 and L5) removed from
oth sides. The feet from each animal were also re-
oved at the time of the sacrifice. Experimental groups
onsisted of four mice per virus for each experiment.
itration of virus in mouse tissues
Four days postinfection mice were killed by cervical
islocation, and the feet and spinal ganglia removed.
otal infections virus present in each tissue was deter-
ined essentially as described previously (Bloom and otevens, 1994). Briefly, the combined spinal ganglia from
ach mouse were homogenized in 300 ml of MEM, and
he combined feet were homogenized in 3.9 ml of MEM.
he homogenates from the feet were collected and cen-
rifuged at 3000 g for 5 min to clear cell debris. Infectious
irus present in each sample was determined by a stan-
ard plaque assay on RSC. The MEM used for homog-
nates of the feet was supplemented with 23 antibiotics
500 U of penicillin and 500 mg of streptomycin/ml) and
mphotericin B (5 mg/ml).
-Gal staining of whole tissues
Mice were sacrificed by perfusion through the left ven-
ricle of the heart 4 days postinfection with 10 ml phos-
hate-buffered saline (PBS), pH 7.2, followed by perfusion
ith 10 ml 4% paraformaldehyde. The feet and spinal gan-
lia were removed and immersed in a formaldehyde/glu-
araldehyde fixative solution (2% formaldehyde, 0.2% glutar-
ldehyde, 0.01% sodium deoxycholate, and 0.02% NP-40 in
BS) for 1 h at 4°C. The tissues were rinsed three times
ith PBS, with a final rinse in 3% DMSO in PBS. The tissues
ere then transferred to b-gal staining solution (5 mM
otassium ferricyanide, 5 mM potassium ferrocyanide, 2
M MgCl2, 0.01% sodium deoxycholate, and 0.02% NP-40
n PBS) containing 1 mg/ml 5-bromo-4-chloro-3-indolyl-b-D-
alactopyranoside (X-Gal) and incubated for 12–14 h at
1°C. The samples were then rinsed two times in PBS and
larified overnight in 50% glycerol in PBS.
nzymatic assay of tissue homogenates
Mice were sacrificed as described above. After tissue
emoval the spinal ganglia were homogenized in 300 ml
f PBS, pH 7.2, and the feet were homogenized in 1.2 ml
f PBS and centrifuged at 3000 g for 5 min to clear cell
ebris. Sixty microliters of each homogenate was added
o 480 ml of chlorophenol red-b-D-galactopyranoside
CPRG) buffer containing 50 mM KPO4 and 1 mM MgCl2
nd 60 ml of CPRG (Boehringer Mannheim) and was
ncubated for 2 h at 37°C and assayed for A573 as in-
tructed by the manufacturer. Uninfected samples spiked
ith a dilution series of pure b-galactosidase (Sigma)
ere used for controls and assayed in the manner de-
cribed above.
ell culture enzymatic assay
Twenty-four-well dishes containing neuro 2A, Vero, or
SCs were grown to confluency as described above.
ach cell line was infected in triplicate with PRV/LAT,
RV/gC, KOS/62-3, KOS/1, dUTPase/LAT, dUTPase/gC, or
7 syn1 at an m.o.i. of 5. At 8 h postinfection the cells
ere scraped into the media and collected by pelleting
t 1500 g for 10 min at 4°C. The pellets were resus-
ended in 200 ml of PBS, pH 7.2, vortexed, and freeze/
hawed four times. Levels of b-galactosidase expression
f each of the viruses in each of the cell lines was
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396 JARMAN, WAGNER, AND BLOOMssayed by measuring b-galactosidase enzymatic activ-
ty in a CPRG assay.
In this assay, an increase in absorbance at 573 nm
hat results when b-galactosidase hydrolyzes the sub-
trate CPRG is measured as a function of time. The
ctivity of known quantities of pure b-galactosidase (dis-
olved in uninfected PBS/cell suspension) was mea-
ured and used to construct a standard curve of rates of
ubstrate conversion as a function of units of b-galacto-
idase. Levels of b-galactosidase in infected cells were
uantitated by measuring rates of substrate conversion
n similar assays and comparing these rates to those in
he standard curve to determine the units of bgalactosi-
ase present. The infected cell suspension was added to
0 ml of CPRG substrate and 480 ml of CPRG buffer and
he absorbance at 573 nm was measured using a Varian
ary BIO 3 UV/VIS spectrophotometer and Varian kinet-
cs software at 37°C for 20 min.
CR and RT–PCR analysis
DNA and RNA from acutely infected feet and DRGs
as isolated by standard protocols. Briefly, the tissues
ere ground in tissue homogenizers with 2 ml (feet) or
00 ml (DRG) guanidine isothiocyanate to which 0.1 vol
odium acetate, pH 2.0, and 2 vol acid-saturated phenol
nd chloroform was added, these samples were centri-
uged at 3000 g to separate layers. The aqueous phase
as precipitated for RNA and the organic phase was
ack extracted three times in 13 TE for DNA recovery.
he DNA was isolated by precipitation with 1/50 vol 5 M
aCl and 3 vol ethanol.
Detection of HSV DNA was accomplished by PCR
nalysis. Briefly, 50-ml reactions containing dilutions of
anglionic or feet DNA; a 0.5 mM concentration of each
rimer for HSV DNA primers: sense b gal (59GAG AAT
TG GGC GCG GAT CCC GTC 39) and antisense (59 GAC
AC AGT ATC GGC AGG AAG 39); 1.5 mM Tris (pH 8.8);
6.6 mM ammonium sulfate; 6.7 mM MgCl2; 0.17 mg/ml
ovine serum albumin; 1.25 mM concentration each of
GTP, dCTP, dATP, and dTTP; 1 mCi of [32P]dCTP (;3000
i/mmol); and 2.5 U of Taq polymerase (Perkin–Elmer
orp, Foster City, CA). The amplification profile was one
ycle of three min each at 94, 68, and 72°C, followed by
n additional 30 cycles, with duration of 1 min at each
emperature. PCR reactions were performed in an Eri-
omp Thermalcycler (San Diego, CA). The 255-bp HSV-
pecific product was resolved in a 5% polyacrylamide
el, exposed to phosphor screen (Molecular Dynamics,
unnyvale, CA) for 24 h, and visualized by a Storm phos-
horimager (Molecular Dynamics). For all experiments, a
rimer pair specific for APRT (sense primer: 59 ACT CAA
GG GCT TCC TGT TTG 39 and antisense primer: 59 ATC
AC AAT GAC CAC TCT CTG 39) was used as an internal
tandard for quantifying total DNA recovery (Bloom et al.,
994; Bloom and Stevens, 1994). This 110-bp productas resolved on a 5% polyacrylamide gel, exposed to a
hosphor screen for 18 h, and visualized on a STORM
hosphorimager. Integration of relative band intensities
as performed using ImageQuant software (Molecular
ynamics).
RNA was reverse transcribed using MLV-reverse tran-
criptase (Gibco) according to the manufacturer’s in-
truction using random hexamer priming. The cDNA was
mplified as described in the PCR analysis above using
-galactosidase primers (255-bp product) and APRT
rimers (186-bp product). These RT-PCR products were
isualized and quantified as described above.
apping of b-galactosidase transcript
DNA and RNA samples from PRV/gC-infected mice
eet were isolated and processed as described above.
he samples were subjected to PCR analysis to deter-
ine if the b-galactosidase RNA was a result of tran-
cription initiated from the PRV promoter. Briefly four
rimer sets were used. P1 (59 GCC AGG GTT TTC CCA
TG ACG ACG 39) is specific for the LacZ gene at base
osition 307–325 relative to the translational start site. P2
59 GCT GCG GCC GGA GCG GTC CAT CTC G 39) is
pecific for the untranslated region 115 to 140 relative
o the predicted transcriptional start site. P3 (59 GGA TGC
CA TCG TGT ATA TAA TCC CC 39) is specific for bases
50 to 226, within the PRV LAT promoter. P4 (59 GGC
CT CAG ATG GTG GCC GGG CGG 39) is specific for
ases 2105 to 2128 within the PRV/LAT promoter.
Primer sets P1/P2, P1/P3, and P1/P4 were used to
dentify the length of cDNA generated from reverse tran-
criptase reactions as described above. DNA and cDNA
solated from PRV/gC infected mice were subjected to
CR as described above using 98°C as melting temper-
ture, 68°C as annealing temperature, and 72°C as ex-
ension temperature. All reactions were PAGE electro-
horesed on a 7.5% gel and exposed to phosphorimager
creens.
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